(This is The Best Stocks in the Market , brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh — Today we’re...
(This is a wrap-up of the key money moving discussions on CNBC’s “Worldwide Exchange” exclusive for PRO subscribers. Worldwide Exchange airs at 5 a.m. ET each...
The Club’s top 10 things to Thursday, Oct. 2 — Matthew J. Belvedere and Kevin Stankiewicz wrote this morning’s newsletter. 1. The S & P 500...
JPMorgan is standing by Bloom Energy even as its stock trades at a signficant premium on data center demand for its onsite power generation systems. The...
Corteva’s pullback following the agricultural technology company’s split announcement just opened up a buying opportunity, according to JPMorgan. Analyst Jeffrey Zekauskas on Thursday upgraded Corteva to...
A trader works at the New York Stock Exchange on Oct. 1, 2025. NYSE Stock futures are little changed Wednesday night after the S&P 500 logged...
Intel’s CEO Lip-Bu Tan speaks at the company’s Annual Manufacturing Technology Conference in San Jose, California, U.S. April 29, 2025. Laure Andrillon | Reuters Intel is...
We are selling 300 shares of Bristol Myers Squibb at roughly $47.66. Following the trade, Jim Cramer’s Charitable Trust will own 1,400 shares of BMY, decreasing...
Not long ago I was coming back from a haircut, a rare trip for me outside the New York Stock Exchange, and I heard a man’s...
